Abstract:Rationale: Systemic injection of the noncompetitive NMDA (N-methyl-D-aspartate) receptor antagonist MK-801 ( dizocilpine maleate) causes both increased locomotion in rodents and various stereotypic behaviors that are proposed to model certain aspects of schizophrenic symptoms in humans. Objectives: This study presents a comprehensive characterization of the bimodal effects of MK-801 on locomotion and stereotypy in the C57BL/6 mouse strain, a strain commonly used for genetically modified mice. Results: We found that it is important to analyze both locomotion and stereotypy in parallel, as MK-801-induced stereotypy results in abnormal movements that are recorded as locomotion by automated beam detection systems. Furthermore, it is important to analyze the bimodal effects of MK-801 over an extended time span, rather than the commonly used narrower time window, as at higher doses ( e. g., above 0.3 mg/kg) the hyperlocomotion phase develops only after the stereotypic phase subsides. We also observed that the apparent dose - response curve is very sensitive to the particular time window chosen for analysis because MK-801 affects both the time course and maximum value of stimulated locomotion. We show that analyzing the absolute peak value of locomotion induced for each animal, rather than group-averaged time courses, provides a measure that is sensitive over a wider range of MK-801 doses. Interestingly, MK-801 even at a very low dose of 0.02 mg/kg suppressed rather than enhanced rearing behavior, differing in this regard from amphetamine. Conclusions: The non-competitive NMDA receptor antagonist MK-801 induces a complex pattern of behavioral modification in mice with respect to both the time course and the dose - response relationship of behavioral changes. The results of this study provide a foundation and frame of reference for the growing interest in studying MK-801-induced behavior in mice.

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Paradoxical Effects of Very Low Dose Mk-801

Age-related Differential Sensitivity to MK-801-induced Locomotion and Stereotypy in C57BL/6 Mice.

Effects of acute treatment of dizocilpine maleate on locomotor activity, prepulse inhibition and object recognition memory in rats n

Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects

MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems

Establishment of a schizophrenia mouse model of deficient sensorimotor gating by MK-801

Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.

Effect of Acute and Chronic MK-801 Administration on Extracellular Glutamate and Ascorbic Acid Release in the Prefrontal Cortex of Freely Moving Mice on Line with Open-Field Behavior

The Effects of Low-Dose MK-801 Treatment on Reference Memory,spatial Working Memory and Reversal Learning in Rats.

Effect of GNTI, a Kappa Opioid Receptor Antagonist, on MK-801-induced Hyperlocomotion and Stereotypy in Mice

Neonatal MK-801 treatment differentially alters the effect of adolescent or adult MK-801 challenge on locomotion and PPI in male and female rats.

[Animal Models of Schizophrenia Using Different Laboratory Mouse Strains].

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

Comparison of effects of the different dosage MK-801 on recognition memory in rats

Aberrant Auditory Steady-State Response of Awake Mice After Single Application of the NMDA Receptor Antagonist MK-801 Into the Medial Geniculate Body

Low dose MK-801 reduces social investigation in mice

Effects of haloperidol on MK-801-induced hyperlocomotion and deficits of prepulse inhibition in mice.

Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats

Sustained Antidepressant Action of the N-methyl-D-aspartate Receptor Antagonist MK-801 in a Chronic Unpredictable Mild Stress Model.